Siegfried Holding AG
SFZN
주식 순위
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
주가
$88.34
시가총액
$3.87B
변동 (1일)
1.68%
변동 (1년)
-12.97%
국가
CH
거래 Siegfried Holding AG (SFZN)
카테고리
Healthcare
Siegfried Holding AG (SFZN)의 주식 분할 이력
Siegfried Holding AG 주식 (심볼: SFZN)은 총 3회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Apr 28, 2025에 발생했습니다.
Jun 23, 1994 이전에 매수한 SFZN 주식 1주는 현재 200주의 SFZN 주식에 해당합니다.
가장 최근의 분할은 Apr 28, 2025에 발생했습니다.
Jun 23, 1994 이전에 매수한 SFZN 주식 1주는 현재 200주의 SFZN 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2025-04-28 | 10:1 | x10 | x200 |
| 2002-08-06 | 10:1 | x10 | x20 |
| 1994-06-23 | 2:1 | x2 | x2 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
